v2.4.0.6
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2012
Stock-Based Compensation [Abstract]  
Summary of option activity

A summary of option activity under all of the above plans as of September 30, 2012 and changes during the nine months then ended is presented in the table below (shares in thousands):

 

                         
    Shares     Wtd. Avg.
Exercise  Price
    Wtd.  Avg.
Remaining
Contractual
Life
 

Outstanding at December 31, 2011

    633     $ 0.90       5.61  

Granted

    10     $ 0.74       6.46  

Exercised

    —       $ —         —    

Forfeited

    —       $ —         —    
   

 

 

                 

Outstanding at September 30, 2012

    643     $ 0.90       4.88  
   

 

 

                 

Vested and expected to vest

    643     $ 0.90       4.88  

Exercisable at September 30, 2012

    450     $ 1.01       4.66  
Summary of non-vested options

A summary of the status of the Company’s non-vested options at September 30, 2012 and changes during the nine months then ended is presented below (shares in thousands):

 

                 
    Shares     Weighted-average
grant-date  fair value
 

Non-vested at December 31, 2011

    349     $ 0.50  

Granted

    10     $ 0.54  

Vested

    (166   $ 0.50  

Forfeited

    —       $ —    
   

 

 

   

 

 

 

Non-vested at September 30, 2012

    193     $ 0.50  
   

 

 

   

 

 

 
Stock-based compensation included in unaudited results of operations

The Company’s stock-based compensation is classified in the same expense line items as cash compensation. Information about stock-based compensation included in the unaudited results of operations for the three and nine months ended September 30, 2012 and 2011 is as follows (in thousands):

 

                                 
    For the Three Months Ended
September 30,
    For the Nine Months  Ended
September 30,
 
    2012     2011     2012     2011  

Officer compensation

  $ 16     $ 11     $ 48     $ 25  

Non-employee directors

    5       3       15       6  

Sales, general and administrative

    6       5       21       14  

Research and development

    30       30       90       90  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total stock option/warrant expense, included in total operating expenses

  $ 57     $ 49     $ 174     $ 135